- Join Australia’s leading university-based commercialisation company
- Apply your knowledge of mining and mineral processing to Create Change
- Drive the transformation of quality intellectual property into global impact
Are you UniQuest’s next dealmaker?
· Do you have an interest in the translation of deep tech?
· Do you have a passion for doing deals that solve industry problems?
· Are you looking to thrive in a collaborative, supportive team environment?
UniQuest is Australia’s leading university commercialisation company. In partnership with UQ researchers, we create impact through the commercialisation of UQ intellectual property (IP). UniQuest’s track record and notable successes include UQ’s Magnetic Resonance Imaging (MRI) technology used in most of the world’s MRI machines; and ResApp Health Ltd, a start-up company that was developing a smartphone technology to identify respiratory diseases. It was acquired by Pfizer Australia in 2022 for $A179 million. Marketed products containing UQ IP licensed by UniQuest have generated gross sales of more than A$73 billion, significantly contributing to societal and economic impact.
Projects in the Physical Sciences portfolio at UniQuest are typically drawn from such disciplines as IT, electrical engineering, chemical engineering, science, and materials science. The common thread is a focus on scalable and sustainable projects leveraging UQ IP to deliver societal and economic impact to the global community.
This role is focused on UQ’s expertise in mining and minerals processing technology. It is linked to UQ’s participation in the Resources Technology and Critical Minerals Trailblazer, designed to promote the commercialisation of technology relevant to the energy transition.
UniQuest has a 2-year fixed term contract position available within the Physical Sciences team as a Director, Commercialisation. Join UniQuest as a Commercialisation Director, and you will:
· Build strong relationships with world-renowned researchers from a university ranked in the world’s top 50;
· Identify and champion new technologies with the potential to create commercially valuable intellectual property;
· Lead business development activities and pitch to industry and venture capital firms;
· Negotiate and close deals within a supported and proven framework; and
· Effectively manage complex scenarios and the competing needs and interests of academic and industry utilising solid influence, persuasion, negotiation and conflict resolution skills.
The successful candidate will be highly motivated, where the opportunities are yours to create. This is a rare and exciting opportunity to join Australia’s leading university commercialisation company.
Our Benefits
We offer a purpose driven role within a collaborative and supportive working environment, excellent benefits including salary packaging, flexible work, purchase leave options to name a few.
This position offers outstanding professional development experiences along with the opportunity to work in an experienced commercialisation team.
The role is based at UniQuest’s offices on UQ’s St Lucia campus, Brisbane, Queensland, Australia.
For a copy of the Position Description please visit our website.
For your application to be considered please apply via Seek. https://www.seek.com.au/job/82040820?tracking=SHR-WEB-SharedJob-anz-1
Applications close Monday 10 March 2025
The Company
UniQuest is the commercialisation company of The University of Queensland (UQ). In partnership with UQ researchers, we create impact through the commercialisation of UQ intellectual property (IP). Established in 1984, UniQuest’s commercialisation track record positions UQ as the leader of research commercialisation in Australasia. UniQuest has formed more than 130 start-up companies built on UQ IP. These companies have raised more than A$1 billion to advance UQ technologies towards the market and have directly created more than 450 new jobs. UniQuest’s track record and notable successes include UQ’s Magnetic Resonance Imaging (MRI) technology used in most of the world’s MRI machines; and ResApp Health Ltd, a start-up company that was developing a smartphone technology to identify respiratory diseases. It was acquired by Pfizer Australia in 2022 for $A179 million. Marketed products containing UQ IP licensed by UniQuest have generated gross sales of more than A$73 billion, significantly contributing to societal and economic impact. UniQuest has also established the Queensland Emory Drug Discovery Initiative (QEDDI), a world-class small molecule drug discovery and development group, dedicated to translating academic biomedical research into drug candidates for partnering.
The University of Queensland (UQ) is one of Australia’s leading teaching and research universities and ranks among the world’s top universities according to several key independent rankings. More than 56,000 current students study at UQ, which has won more national teaching awards than any other Australian university. UQ’s research has global impact, delivered by an interdisciplinary community of more than 1500 researchers across six faculties, eight globally recognised research institutes and 100+ research centres.
